# Urin-based Point-of-Care Testing for Direct Oral Anticoagulants in Stroke Patients

> **NCT06037200** · — · UNKNOWN · sponsor: **University of Giessen** · enrollment: 200 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DEVICE:** Urin-based test by the DOASENSE Dipstick Device

## Key facts

- **NCT ID:** NCT06037200
- **Lead sponsor:** University of Giessen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-07-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06037200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06037200, "Urin-based Point-of-Care Testing for Direct Oral Anticoagulants in Stroke Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06037200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
